Nelson Rhodes

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo.

David W. Rusnak, Karen Lackey, Karen Affleck et al. · PubMed · 2001 · 737 citations

Pathology, Cell Proliferation, Cell Growth +16

Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity

Nelson Rhodes, Dirk A. Heerding, Derek R. Duckett et al. · Cancer Research · 2008 · 296 citations · Full text

Tumor Xenografts, Antitumor Activity, Chemoprevention Strategy +21

Constitutive mutants of the protein kinase STE11 activate the yeast pheromone response pathway in the absence of the G protein.

Brian J. Stevenson, Nelson Rhodes, Beverly Errede et al. · Genes & Development · 1992 · 288 citations · Full text

Molecular Regulation, Genetics, Genomic Mechanism +23

Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study

Xue Ming, T. Peter Stein, Virginia Monsul Barnes et al. · Journal of Proteome Research · 2012 · 237 citations

Nutrition, Asd Children, Biochemistry +12

STE11 is a protein kinase required for cell-type-specific transcription and signal transduction in yeast.

Nelson Rhodes, Laurie B. Connell, Beverly Errede · Genes & Development · 1990 · 176 citations · Full text

Ste11 Gene, Genetics, Molecular Biology +19